Highly effective and improved drug therapies along with the newly implemented screening guidelines, could make hepatitis C a rare disease in the United States by 2036, suggest the results of a predictive model developed at the University of Pittsburgh Graduate School of Public Health. The results of the analysis, funded by the National Institutes of Health (NIH) and performed with the University of Texas MD Anderson Cancer Center, are published in the Aug. 5 issue ...Tuesday 5 August 2014
Hepatitis C Screening and Drug Therapy Could Make It a Rare Disease
Highly effective and improved drug therapies along with the newly implemented screening guidelines, could make hepatitis C a rare disease in the United States by 2036, suggest the results of a predictive model developed at the University of Pittsburgh Graduate School of Public Health. The results of the analysis, funded by the National Institutes of Health (NIH) and performed with the University of Texas MD Anderson Cancer Center, are published in the Aug. 5 issue ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment